Kimbra Kenney, MD

Kimbra Kenney, MD

Name: Kimbra Kenney, MD

USU Department of Primary Appointment: 
Neurology
Faculty Rank: 
Associate Professor
Location: 
Walter Reed National Military Medical Center, Bethesda, MD

Research Interests:
TBI
Prion disease

Office Phone: 
(301) 400-0942

Education

BA, The Johns Hopkins University, Baltimore, MD, 1980
MD, University of Virginia School of Medicine, Charlottesville, VA, 1984
Internship, Harbour-UCLA, Los Angeles, CA, 1985, Internal Medicine
Residency, Oregon Health Sciences University, Portland, OR, 1988, Neurology
Fellowship, University of Washington, Seattle, WA, 1989, Neuropathology
Clinical Associate, Laboratory of Central Nervous System Studies, NINDS, NIH, 1993-2001, Transmissible spongiform encephalopathies

Bibliography

  • Brown PW, Kenney K, et al., The intracerebral distribution of infectious amyloid protein in patients with spongiform encephalopathy. Annals Neurology 38: 2 (August), 245-253, 1995.
  • Alperovitch A, Bradley R, Diringer H, Gibbs J, Kenney K, et al. Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies. Bulletin World Health Org 74 (5):453-463, 1996.
  • Hsich G, Kenney K, Gibbs CJ, Lee K, et al., The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. The New England J Medicine, 38 (No. 13, September 26): 924-930, 1996.
  • Will RG, Zeidler M, Brown P, Harrington M, Lee K, Kenney K, Cerebrospinal fluid test for new-variant Creutzfeldt-Jakob disease. Lancet, 348 (October 5): 955, 1996.
  • Bird T, Kraft G, Lipe, Kenney K, Sumi M, Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20 year study, Annals Neurology 41: 4 (April), 463-369, 1997.
  • Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O’Brien K, Campbell WW. Serum CK after exercise - drawing the line between physiologic response and exertional rhabdomyolysis? Muscle and Nerve, 2012. Mar;45(3):356–362.
  • Kenney K, Amyot F, Haber M, Pronger A, Bogoslovsky T, Moore C, Diaz-Arrastia R. Vascular Injury in Traumatic Brain Injury. Exp Neurol. 2016;275(3):353-366.
  • Amyot F, Kenney K, Moore C, Haber M, Turtzo LC, Shenouda C, Silverman E, Harburg L, Gandhbakjche A, Wassermann E, Diaz-Arrastia R. Imaging of Cerebrovascular Function in Chronic Traumatic Brain Injury. J Neurotrauma 2017 Oct 25. doi: 10.1089/neu.2017.5114. [Epub ahead of print].
  • Kenney K, Katz DI, Edlow BL, Diaz-Arrastia R, Daneshvar DH, Dams-O’Connor K, Stevens A, Moreau A, Tirrel L, Varjabedian A, Yendiki A, van der Kouwe A, McNab JA, Gordon WA, Fischl B, McKee AC, Perl DP. Dementia after Single Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple Proteinopathies. J Neuropath Exp Neur, 2018;77(1):50-63.
  • Kenney K, Amyot F, Moore C, Haber M, Moore C, Turtzo LC, Shenouda C, Silverman E, Gong Y, Qu B, Harburg L, Wassermann E, Lu HY, Diaz-Arrastia R. Phosphodiesterase-5 Inhibition Potentiates Cerebrovascular Reactivity in Chronic Traumatic Brain Injury. Ann Clin Trans Neur, in press, 12-28-2017.